Veterinary Molecular Diagnostics Market

Veterinary Molecular Diagnostics Market Insights

Molecular diagnostics is the method of detection, tracking, and identification, genotyping of viruses, bacteria, and parasites. It is a series of techniques performed to biologically analyze the markers in genome and proteome. The study used to conduct molecular diagnostics amongst animals are molecular biology. The applications are found in the pathological examination. Veterinary molecular diagnostics completely focus on animal and their molecular system. With the drastic impact of COVID-19, many industries had to stop the operations simultaneously and many individuals got infected by the novel coronavirus and lost their lives traumatizing mankind terribly. With the increasing number of cases, it was important to focus more on the healthcare segment than any other to curb the crisis. This progress resulted in the upliftment of the veterinary molecular diagnostic market and is predicted to prevail at a great elevation in the upcoming years.

According to the inferences done by GME, the veterinary molecular diagnostics market is estimated to record a  growth of 8.8% between the period (2020-2026).

An increase in pet care costs is the main hindrance towards the development of the market whereas, an increase in the animal population, demand for animal diagnostics products, and rising demand for animal-derived food products are analyzed to be prominent thrusters influencing the market.

Veterinary Molecular Diagnostics Market: By Type of Product

PCR kits, INAAT kits, microarray kits, and DNA sequencing kits are the various types of products witnessed in the global market where RT-PCR kits and RAPD-PCR kits are the classifications of PCR kits. The segment to have extensive market share is PCR kits. Widespread awareness of animal health is one of the major drivers influencing the market.

Veterinary Molecular Diagnostics Market: By Type of Disease

Based on the diseases, the market bifurcation can be seen as Anaplasma spp., porcine reproductive & respiratory syndrome (PRRS), Ehrlichia spp.,  and others. Influenza is seen in the fastest-growing segment in the forecast period. An increase in expenditure towards research & development is one of the primary propellors of the global market.

Veterinary Molecular Diagnostics Market: By Type of Species

The market segmentation based on species is livestock animals and companion animals. Equine, porcine, poultry, bovine/cattle, aquatic, and ovine are the livestock animals and canine, feline, and avian are the companion animal species respectively. The companion animals are estimated to have a huge market within 2020-2026. Demand for companion animal ownership is the prime accelerator towards the development in the global market.

Veterinary Molecular Diagnostics Market: By End-User

Based on end-users, clinical laboratories, veterinary hospitals, and veterinary research institutes are the categorization of the market. Veterinary hospitals are projected to account for a huge market chunk during  the forecast period. An increase in hospital expenditure across various companies is one of the notable propellors of this market.

Veterinary Molecular Diagnostics Market: By Region

Based on the geographical analysis, the Asia Pacific region will emerge as a potential player during the forecast period. An increase in the number of veterinary practitioners, the prevalence of zoonotic diseases, and growing pet health expenditure can be determined as the factors affecting the growth of the global veterinary molecular diagnostics market.

Market Share and Competitor Analysis

bioMérieux SA, IDEXX Laboratories Inc., INDICAL BIOSCIENCE GmbH, Thermo Fisher Scientific Inc., Neogen Corporation, Qiagen N.V., ID.Vet and other industries are suppliers in the market.

Please note: This is not an exhaustive list of companies profiled in the report.

In April 2018, Randox Laboratories initiated the production of Vivalytic.

In January 2018,  IDEXX Laboratories Inc. started the clinical trials for the SDMA test.